Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1141021

Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy


Radmilović Varga, Ljubica; Dedić Plavetić, Natalija; Podolski, Paula; Kulić, Ana; Mijatović, Davor; Vrbanec Damir
Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy // Acta clinica Croatica, 60 (2021), 1; 16-24 doi:10.20471/acc.2021.60.01.03 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1141021 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy

Autori
Radmilović Varga, Ljubica ; Dedić Plavetić, Natalija ; Podolski, Paula ; Kulić, Ana ; Mijatović, Davor ; Vrbanec Damir

Izvornik
Acta clinica Croatica (0353-9466) 60 (2021), 1; 16-24

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
breast cancer ; prognosis ; outcome ; adjuvant chemotherapy ; B-Myb ; Topo2a

Sažetak
Breast cancer is the most common malignancy in females. Despite its well-established prognostic factors, our prognostic ability at an individual patient level remains limited. In this study, the immunohistochemical expression of B-Myb and DNA topoisomerase 2-alpha (Topo2a) was analyzed in primary tumors to identify patients with a higher risk of disease recurrence after adjuvant chemotherapy for early invasive breast cancer. We analyzed a cohort of 215 early invasive breast cancer patients having undergone surgery from 2002 to 2003 at the Zagreb University Hospital Centre, including 153 patients treated with adjuvant chemotherapy. All of them were followed-up prospectively for at least ten years according to routine institutional practice. Statistically significant correlations were found between B-Myb and Topo2a expression levels and particular well- established prognostic factors. B-Myb expression was lower in estrogen receptor (ER)-positive tumors (p=0.0773), whereas larger tumors and those with positive lymphovascular invasion displayed a statistically significantly higher B-Myb expression (p=0.0409 and p=0.0196). Higher tumor grade indicated higher Topo2a values (p=0.0102 and p=0.0069). The subgroup with the expression of both proteins above the median value had an almost statistically significantly (p=0.0613) inferior prognosis compared to the rest of the cohort. Study results showed the B-Myb and Topo2a expression to have a prognostic value in breast cancer patients after adjuvant chemotherapy, which should be additionally explored in future studies in a larger patient cohort.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Varaždin,
Klinički bolnički centar Zagreb,
Sveučilište Jurja Dobrile u Puli

Poveznice na cjeloviti tekst rada:

doi hrcak.srce.hr

Citiraj ovu publikaciju:

Radmilović Varga, Ljubica; Dedić Plavetić, Natalija; Podolski, Paula; Kulić, Ana; Mijatović, Davor; Vrbanec Damir
Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy // Acta clinica Croatica, 60 (2021), 1; 16-24 doi:10.20471/acc.2021.60.01.03 (međunarodna recenzija, članak, znanstveni)
Radmilović Varga, L., Dedić Plavetić, N., Podolski, P., Kulić, A., Mijatović, D. & Vrbanec Damir (2021) Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy. Acta clinica Croatica, 60 (1), 16-24 doi:10.20471/acc.2021.60.01.03.
@article{article, author = {Radmilovi\'{c} Varga, Ljubica and Dedi\'{c} Plaveti\'{c}, Natalija and Podolski, Paula and Kuli\'{c}, Ana and Mijatovi\'{c}, Davor}, year = {2021}, pages = {16-24}, DOI = {10.20471/acc.2021.60.01.03}, keywords = {breast cancer, prognosis, outcome, adjuvant chemotherapy, B-Myb, Topo2a}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2021.60.01.03}, volume = {60}, number = {1}, issn = {0353-9466}, title = {Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy}, keyword = {breast cancer, prognosis, outcome, adjuvant chemotherapy, B-Myb, Topo2a} }
@article{article, author = {Radmilovi\'{c} Varga, Ljubica and Dedi\'{c} Plaveti\'{c}, Natalija and Podolski, Paula and Kuli\'{c}, Ana and Mijatovi\'{c}, Davor}, year = {2021}, pages = {16-24}, DOI = {10.20471/acc.2021.60.01.03}, keywords = {breast cancer, prognosis, outcome, adjuvant chemotherapy, B-Myb, Topo2a}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2021.60.01.03}, volume = {60}, number = {1}, issn = {0353-9466}, title = {Prognostic value of topoisomerase 2-alpha and B- Myb in early breast cancer treated with adjuvant chemotherapy}, keyword = {breast cancer, prognosis, outcome, adjuvant chemotherapy, B-Myb, Topo2a} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font